カテゴリ： QYResearch, 世界, 医療/バイオ

アンチセンスオリゴヌクレオチド療法の世界市場2023年：GalNAc結合なし、GalNAc結合あり

■ 英語タイトル：Global Antisense Oligonucleotide Therapies Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8677）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8677
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：69
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アンチセンスオリゴヌクレオチド療法の世界市場2023年：GalNAc結合なし、GalNAc結合あり]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はアンチセンスオリゴヌクレオチド療法のグローバル市場について調査・分析し、世界のアンチセンスオリゴヌクレオチド療法市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（GalNAc結合なし、GalNAc結合あり）、用途別セグメント分析（遺伝病、がん、循環器疾患、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Ionis Pharmaceuticals、Sarepta Therapeutics、Nippon Shinyakuなどが含まれています。アンチセンスオリゴヌクレオチド療法のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、アンチセンスオリゴヌクレオチド療法市場規模を算出する際に考慮しました。

・アンチセンスオリゴヌクレオチド療法市場の概要
- アンチセンスオリゴヌクレオチド療法の種類別セグメント
- 世界のアンチセンスオリゴヌクレオチド療法市場規模：タイプ別分析（GalNAc結合なし、GalNAc結合あり）
- アンチセンスオリゴヌクレオチド療法の用途別セグメント
- 世界のアンチセンスオリゴヌクレオチド療法市場規模：用途別分析（遺伝病、がん、循環器疾患、その他）
- 世界のアンチセンスオリゴヌクレオチド療法市場規模予測（2018年-2029年）

・アンチセンスオリゴヌクレオチド療法市場の成長トレンド
- アンチセンスオリゴヌクレオチド療法の地域別市場規模（2018年-2029年）
- アンチセンスオリゴヌクレオチド療法市場ダイナミクス
- アンチセンスオリゴヌクレオチド療法の業界動向
- アンチセンスオリゴヌクレオチド療法市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：GalNAc結合なし、GalNAc結合あり
- 世界のアンチセンスオリゴヌクレオチド療法のタイプ別市場規模（2018年-2023年）
- 世界のアンチセンスオリゴヌクレオチド療法のタイプ別市場規模（2024年-2029年）

・用途別セグメント：遺伝病、がん、循環器疾患、その他
- 世界のアンチセンスオリゴヌクレオチド療法の用途別市場規模（2018年-2023年）
- 世界のアンチセンスオリゴヌクレオチド療法の用途別市場規模（2024年-2029年）

・アンチセンスオリゴヌクレオチド療法の地域別市場規模
- 北米のアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- 米国のアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- ヨーロッパのアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- アジア太平洋のアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- 中国のアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- 日本のアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- 韓国のアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- インドのアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- オーストラリアのアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- 中南米のアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）
- 中東・アフリカのアンチセンスオリゴヌクレオチド療法市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Ionis Pharmaceuticals、Sarepta Therapeutics、Nippon Shinyaku

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Antisense Oligonucleotide Therapies market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Antisense Oligonucleotide Therapies is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Antisense Oligonucleotide Therapies is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Antisense Oligonucleotide Therapies in Genetic Disease is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Antisense Oligonucleotide Therapies include Ionis Pharmaceuticals, Sarepta Therapeutics and Nippon Shinyaku, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotide Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotide Therapies.
The Antisense Oligonucleotide Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antisense Oligonucleotide Therapies market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Oligonucleotide Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
Segment by Type
Without GalNAc-conjugated
With GalNAc-conjugated
Segment by Application
Genetic Disease
Cancer
Cardiovascular Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense Oligonucleotide Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Oligonucleotide Therapies Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Without GalNAc-conjugated
1.2.3 With GalNAc-conjugated
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotide Therapies Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Genetic Disease
1.3.3 Cancer
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Oligonucleotide Therapies Market Perspective (2018-2029)
2.2 Antisense Oligonucleotide Therapies Growth Trends by Region
2.2.1 Global Antisense Oligonucleotide Therapies Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antisense Oligonucleotide Therapies Historic Market Size by Region (2018-2023)
2.2.3 Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2024-2029)
2.3 Antisense Oligonucleotide Therapies Market Dynamics
2.3.1 Antisense Oligonucleotide Therapies Industry Trends
2.3.2 Antisense Oligonucleotide Therapies Market Drivers
2.3.3 Antisense Oligonucleotide Therapies Market Challenges
2.3.4 Antisense Oligonucleotide Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Oligonucleotide Therapies Players by Revenue
3.1.1 Global Top Antisense Oligonucleotide Therapies Players by Revenue (2018-2023)
3.1.2 Global Antisense Oligonucleotide Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Antisense Oligonucleotide Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense Oligonucleotide Therapies Revenue
3.4 Global Antisense Oligonucleotide Therapies Market Concentration Ratio
3.4.1 Global Antisense Oligonucleotide Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotide Therapies Revenue in 2022
3.5 Antisense Oligonucleotide Therapies Key Players Head office and Area Served
3.6 Key Players Antisense Oligonucleotide Therapies Product Solution and Service
3.7 Date of Enter into Antisense Oligonucleotide Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Oligonucleotide Therapies Breakdown Data by Type
4.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Type (2018-2023)
4.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2024-2029)
5 Antisense Oligonucleotide Therapies Breakdown Data by Application
5.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Application (2018-2023)
5.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antisense Oligonucleotide Therapies Market Size (2018-2029)
6.2 North America Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antisense Oligonucleotide Therapies Market Size by Country (2018-2023)
6.4 North America Antisense Oligonucleotide Therapies Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Oligonucleotide Therapies Market Size (2018-2029)
7.2 Europe Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antisense Oligonucleotide Therapies Market Size by Country (2018-2023)
7.4 Europe Antisense Oligonucleotide Therapies Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotide Therapies Market Size (2018-2029)
8.2 Asia-Pacific Antisense Oligonucleotide Therapies Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2018-2023)
8.4 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Oligonucleotide Therapies Market Size (2018-2029)
9.2 Latin America Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2018-2023)
9.4 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotide Therapies Market Size (2018-2029)
10.2 Middle East & Africa Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2018-2023)
10.4 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Detail
11.1.2 Ionis Pharmaceuticals Business Overview
11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Introduction
11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapies Business (2018-2023)
11.1.5 Ionis Pharmaceuticals Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Detail
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Antisense Oligonucleotide Therapies Introduction
11.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotide Therapies Business (2018-2023)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku Company Detail
11.3.2 Nippon Shinyaku Business Overview
11.3.3 Nippon Shinyaku Antisense Oligonucleotide Therapies Introduction
11.3.4 Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapies Business (2018-2023)
11.3.5 Nippon Shinyaku Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antisense Oligonucleotide Therapies Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Without GalNAc-conjugated
Table 3. Key Players of With GalNAc-conjugated
Table 4. Global Antisense Oligonucleotide Therapies Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Antisense Oligonucleotide Therapies Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Antisense Oligonucleotide Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Antisense Oligonucleotide Therapies Market Share by Region (2018-2023)
Table 8. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Antisense Oligonucleotide Therapies Market Share by Region (2024-2029)
Table 10. Antisense Oligonucleotide Therapies Market Trends
Table 11. Antisense Oligonucleotide Therapies Market Drivers
Table 12. Antisense Oligonucleotide Therapies Market Challenges
Table 13. Antisense Oligonucleotide Therapies Market Restraints
Table 14. Global Antisense Oligonucleotide Therapies Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Antisense Oligonucleotide Therapies Market Share by Players (2018-2023)
Table 16. Global Top Antisense Oligonucleotide Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2022)
Table 17. Ranking of Global Top Antisense Oligonucleotide Therapies Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Antisense Oligonucleotide Therapies Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antisense Oligonucleotide Therapies Product Solution and Service
Table 21. Date of Enter into Antisense Oligonucleotide Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense Oligonucleotide Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2018-2023)
Table 25. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2029)
Table 27. Global Antisense Oligonucleotide Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2018-2023)
Table 29. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2029)
Table 31. North America Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Antisense Oligonucleotide Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Antisense Oligonucleotide Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Antisense Oligonucleotide Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Antisense Oligonucleotide Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Antisense Oligonucleotide Therapies Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 46. Ionis Pharmaceuticals Company Detail
Table 47. Ionis Pharmaceuticals Business Overview
Table 48. Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Product
Table 49. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapies Business (2018-2023) & (US$ Million)
Table 50. Ionis Pharmaceuticals Recent Development
Table 51. Sarepta Therapeutics Company Detail
Table 52. Sarepta Therapeutics Business Overview
Table 53. Sarepta Therapeutics Antisense Oligonucleotide Therapies Product
Table 54. Sarepta Therapeutics Revenue in Antisense Oligonucleotide Therapies Business (2018-2023) & (US$ Million)
Table 55. Sarepta Therapeutics Recent Development
Table 56. Nippon Shinyaku Company Detail
Table 57. Nippon Shinyaku Business Overview
Table 58. Nippon Shinyaku Antisense Oligonucleotide Therapies Product
Table 59. Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapies Business (2018-2023) & (US$ Million)
Table 60. Nippon Shinyaku Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense Oligonucleotide Therapies Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Antisense Oligonucleotide Therapies Market Share by Type: 2022 VS 2029
Figure 3. Without GalNAc-conjugated Features
Figure 4. With GalNAc-conjugated Features
Figure 5. Global Antisense Oligonucleotide Therapies Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Antisense Oligonucleotide Therapies Market Share by Application: 2022 VS 2029
Figure 7. Genetic Disease Case Studies
Figure 8. Cancer Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Other Case Studies
Figure 11. Antisense Oligonucleotide Therapies Report Years Considered
Figure 12. Global Antisense Oligonucleotide Therapies Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Antisense Oligonucleotide Therapies Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Antisense Oligonucleotide Therapies Market Share by Region: 2022 VS 2029
Figure 15. Global Antisense Oligonucleotide Therapies Market Share by Players in 2022
Figure 16. Global Top Antisense Oligonucleotide Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Antisense Oligonucleotide Therapies Revenue in 2022
Figure 18. North America Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Antisense Oligonucleotide Therapies Market Share by Country (2018-2029)
Figure 20. United States Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Antisense Oligonucleotide Therapies Market Share by Country (2018-2029)
Figure 24. Germany Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Antisense Oligonucleotide Therapies Market Share by Region (2018-2029)
Figure 32. China Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Antisense Oligonucleotide Therapies Market Share by Country (2018-2029)
Figure 40. Mexico Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Antisense Oligonucleotide Therapies Market Share by Country (2018-2029)
Figure 44. Turkey Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2018-2023)
Figure 47. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2018-2023)
Figure 48. Nippon Shinyaku Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のオリゴヌクレオチド合成市場2023-2030：市場規模、シェア、動向分析
  • 顔面紅斑治療のグローバル市場展望 2023年-2029年：Rx、OTC
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8677 )"アンチセンスオリゴヌクレオチド療法の世界市場2023年：GalNAc結合なし、GalNAc結合あり" (英文：Global Antisense Oligonucleotide Therapies Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。